NO20014393D0 - 1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse - Google Patents

1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse

Info

Publication number
NO20014393D0
NO20014393D0 NO20014393A NO20014393A NO20014393D0 NO 20014393 D0 NO20014393 D0 NO 20014393D0 NO 20014393 A NO20014393 A NO 20014393A NO 20014393 A NO20014393 A NO 20014393A NO 20014393 D0 NO20014393 D0 NO 20014393D0
Authority
NO
Norway
Prior art keywords
preparation
oxadiazole derivatives
oxadiazole
derivatives
Prior art date
Application number
NO20014393A
Other languages
English (en)
Other versions
NO20014393L (no
Inventor
Tsutomu Kojima
Katsutoshi Hachiya
Kazuyuki Ohmoto
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of NO20014393D0 publication Critical patent/NO20014393D0/no
Publication of NO20014393L publication Critical patent/NO20014393L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20014393A 1999-03-12 2001-09-10 1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse NO20014393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6606599 1999-03-12
PCT/JP2000/001464 WO2000055145A1 (en) 1999-03-12 2000-03-10 1,3,4-oxadiazole derivatives and process for producing the same

Publications (2)

Publication Number Publication Date
NO20014393D0 true NO20014393D0 (no) 2001-09-10
NO20014393L NO20014393L (no) 2001-11-08

Family

ID=13305090

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014393A NO20014393L (no) 1999-03-12 2001-09-10 1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse

Country Status (16)

Country Link
US (2) US6534658B1 (no)
EP (1) EP1162199A4 (no)
KR (1) KR20010102569A (no)
CN (1) CN1350525A (no)
AU (1) AU2941200A (no)
BR (1) BR0008936A (no)
CA (1) CA2367418A1 (no)
HU (1) HUP0200476A3 (no)
MX (1) MXPA01009165A (no)
NO (1) NO20014393L (no)
NZ (1) NZ513921A (no)
RU (1) RU2001124908A (no)
TR (1) TR200102680T2 (no)
TW (1) TW482763B (no)
WO (1) WO2000055145A1 (no)
ZA (1) ZA200107256B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300266A3 (en) * 2000-02-03 2003-10-28 Ono Pharmaceutical Co 1,3,4-oxadiazole derivatives and process for producing the same
JPWO2002014310A1 (ja) * 2000-08-10 2004-01-15 小野薬品工業株式会社 2−[5−アミノ−6−オキソ−2−フェニル−1,6−ジヒドロ−1−ピリミジル]−N−[1−(2−[5−t−ブチル−1,3,4−オキサジアゾリル]カルボニル)−2−(R,S)−メチルプロピル]アセトアミド・塩酸塩化合物
EP1318150A4 (en) * 2000-09-08 2004-04-14 Ono Pharmaceutical Co NEW CRYSTALS OF 1,3,4-OXADIAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION OF THE CRYSTALS AND THE MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE SUBSTANCE
JPWO2002051815A1 (ja) * 2000-12-26 2004-04-22 小野薬品工業株式会社 ピリミジン誘導体化合物およびそれらの製造方法
EP1697331A4 (en) * 2003-12-19 2010-08-04 Merck Sharp & Dohme INHIBITORS OF MITOTIC KINESINE
KR20090086802A (ko) 2008-02-11 2009-08-14 삼성전자주식회사 옥사디아졸렌기를 포함하는 디페노퀴논계 화합물을포함하는 전자사진 감광체 및 이를 채용한 전자사진화상형성장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US5618792A (en) 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US5591695A (en) * 1995-02-08 1997-01-07 American Cyanamid Co. Herbicidal [1,3,4]oxadiazoles and thiadiazoles
HUP0100669A3 (en) * 1996-12-06 2001-12-28 Cortech Inc Denver Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof

Also Published As

Publication number Publication date
HUP0200476A2 (en) 2002-08-28
WO2000055145A1 (en) 2000-09-21
US20030153758A1 (en) 2003-08-14
TW482763B (en) 2002-04-11
RU2001124908A (ru) 2004-02-27
KR20010102569A (ko) 2001-11-15
HUP0200476A3 (en) 2004-03-29
TR200102680T2 (tr) 2002-07-22
ZA200107256B (en) 2002-12-02
CA2367418A1 (en) 2000-09-21
NO20014393L (no) 2001-11-08
BR0008936A (pt) 2002-04-09
US6534658B1 (en) 2003-03-18
MXPA01009165A (es) 2002-08-20
CN1350525A (zh) 2002-05-22
NZ513921A (en) 2001-09-28
EP1162199A1 (en) 2001-12-12
EP1162199A4 (en) 2002-06-05
AU2941200A (en) 2000-10-04

Similar Documents

Publication Publication Date Title
NO20020687L (no) 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
NO20014013L (no) 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1112251T3 (da) Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
NO20024281D0 (no) Indolderivater, fremgangsmåte for fremstilling av de samme og anvendelse derav
CY2013003I2 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
IS5875A (is) Ásetnar fenýlafleiður, framleiðsla þeirra og notkun
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
IS2076B (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20030800L (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
NO20013900L (no) Epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
NO20013237D0 (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
NO20001336L (no) Modifisert celluloseprodukt og fremgangsmÕte for fremstilling av dette
NO20001909D0 (no) Fremgangsmõte og anlegg for fremstilling av 1,2-dikloretan
DK1627631T3 (da) Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme
DK0838469T3 (da) 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
NO20014393L (no) 1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse
NO20013878L (no) (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme
NO20000182L (no) Fremgangsmåte for fremstilling av alkoksyfuranonamin- derivater, forbindelser frembragt ved fremgangsmåten og anvendelse av disse forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application